Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/09/2010 | WO2009149106A3 Microparticles for the treatment of disease |
12/09/2010 | WO2009142525A3 Capsulating system binding to nucleolin |
12/09/2010 | US20100312328 Drug-delivery endovascular stent and method of forming the same |
12/09/2010 | US20100312191 Microneedle Devices and Methods of Manufacture and Use Thereof |
12/09/2010 | US20100311944 Cyclosporine analogue mixtures and their use as immunomodulating agents |
12/09/2010 | US20100311802 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
12/09/2010 | US20100311707 Controlled release delivery system for nasal applications and methods of treatment |
12/09/2010 | US20100311706 Method of treatment of allergic rhinitis |
12/09/2010 | US20100311705 Ophthalmologic irrigation solutions and method |
12/09/2010 | US20100311662 Treatment of Acute Coronary Syndrome with an Exendin |
12/09/2010 | US20100311595 Lipophilic drug delivery vehicle and methods of use thereof |
12/09/2010 | US20100310671 Encapsulated low viscosity hydrophobic liquid actives |
12/09/2010 | US20100310670 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same |
12/09/2010 | US20100310669 Dispersion of Poloxamer- Protein Particles, Methods of Manufacturing and Uses Thereof |
12/09/2010 | US20100310668 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide |
12/09/2010 | US20100310667 Controlled-release floating pharmaceutical compositions |
12/09/2010 | US20100310666 Delivery of Functional Compounds |
12/09/2010 | US20100310665 Bacteriostatic or bacteriocidal compositions and methods |
12/09/2010 | US20100310664 Compositions and methods for treating insulin resistance and diabetes mellitus |
12/09/2010 | US20100310663 Pharmaceutical compositions comprising nanoparticles and a resuspending material |
12/09/2010 | US20100310662 Oral Drug Delivery System for Azole, Moxifloxacin and Rifampicin |
12/09/2010 | US20100310661 Oral formulations for picoplatin |
12/09/2010 | US20100310660 Dry powder microparticles for pulmonary delivery |
12/09/2010 | US20100310659 Compositions and Uses Thereof |
12/09/2010 | US20100310658 Electroprocessed Fibrin-Based Matrices and Tissues |
12/09/2010 | US20100310657 Pharmaceutical composition for treatment and prevention of kidney diseases |
12/09/2010 | US20100310656 Immunotherapy and prevention of autoimmune hepatitis |
12/09/2010 | US20100310655 Crystal modification A of 1-(2,6-difluorobenzyl)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof |
12/09/2010 | US20100310654 Homeopathic remedies for use before and after aesthetic injectable and surgical procedures to minimize swelling and bruising |
12/09/2010 | US20100310653 Use of an extract made of leaves of ginkgo biloba |
12/09/2010 | US20100310652 Coated extended release pharmaceutical compositions of levetiracetam |
12/09/2010 | US20100310651 Solid pharmaceutical compositions and processes for their production |
12/09/2010 | US20100310650 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation |
12/09/2010 | US20100310649 Solid lipid microcapsules containing growth hormone inner core microparticles |
12/09/2010 | US20100310648 Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor |
12/09/2010 | US20100310647 Enzymatic Synthesis of Polymers |
12/09/2010 | US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4 |
12/09/2010 | US20100310645 Methods for inhibiting tumor cell proliferation |
12/09/2010 | US20100310644 Anti-dandruff compositions containing peptides |
12/09/2010 | US20100310643 Cd133 epitopes |
12/09/2010 | US20100310642 Topical Drug Delivery Systems for Ophthalmic Use |
12/09/2010 | US20100310641 Therapeutic approaches for treating cmt and related disorders |
12/09/2010 | US20100310640 Hla-dr binding peptides and their uses |
12/09/2010 | US20100310639 Immuno-modulatory composition |
12/09/2010 | US20100310638 Liposomes comprising duramycin and anti-viral agents |
12/09/2010 | US20100310637 Composition and method for the treatment or prevention of glaucoma and ocular hypertension |
12/09/2010 | US20100310636 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof |
12/09/2010 | US20100310635 Compositions and Methods for Regulating T-Cell Activity |
12/09/2010 | US20100310634 Transdermal therapeutic system having urea components |
12/09/2010 | US20100310632 Micro-membrane implant with cusped opening |
12/09/2010 | US20100310631 Filament based on hyaluronic acid in the form of free acid and method for obtaining it |
12/09/2010 | US20100310630 Coated surface for cell culture |
12/09/2010 | US20100310621 Controlled Iodine Release Particle Micro-Biocide |
12/09/2010 | US20100310619 Sonny's Miracle |
12/09/2010 | US20100310613 Drug delivery system |
12/09/2010 | US20100310612 Medicament for the Treatment of Cancer of the Pancreas |
12/09/2010 | US20100310611 Parenteral and oral formulations of benzimidazoles |
12/09/2010 | US20100310610 Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems |
12/09/2010 | US20100310609 Compositions and methods for treatment of neurodegenerative diseases |
12/09/2010 | US20100310608 Sequestering subunit and related compositions and methods |
12/09/2010 | US20100310607 Pharmaceutical formulations |
12/09/2010 | US20100310477 Pharmaceutical compositions based on anticholingerics and additional active ingredients |
12/09/2010 | US20100310476 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
12/09/2010 | US20100310475 Biocide Capsules, Preparation Comprising them and Sanitary Pad Comprising the Preparation |
12/09/2010 | US20100310465 Nano-devices having releasable seals for controlled release of molecules |
12/09/2010 | US20100310464 Antibodies |
12/09/2010 | US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy |
12/09/2010 | DE202009018024U1 Quetiapin-Zusammensetzung Quetiapine composition |
12/09/2010 | DE102009013469A1 Zubereitung zur äußerlichen Anwendung Preparation for external use |
12/09/2010 | DE10200657B4 2:1-Komplex aus β- oder γ-Cyclodextrin und α-Tocopherol 2: 1 complex of β- or γ-cyclodextrin and α-tocopherol |
12/09/2010 | DE102005011367B4 Verfahren zur Herstellung von Cellulosesulfat mit verbesserten Eigenschaften A process for the production of cellulose sulfate with improved characteristics |
12/09/2010 | CA2841499A1 Compositions and methods for preventing sternal wound infections |
12/09/2010 | CA2764517A1 Dosage form |
12/09/2010 | CA2764482A1 Compositions and methods for delivery of materials |
12/09/2010 | CA2764477A1 Ophthalmic formulations, methods of manufacture, and methods of using same |
12/09/2010 | CA2764424A1 Vaccine for mycoplasma infection |
12/09/2010 | CA2764329A1 Omega-3 oil containing ophthalmic emulsions |
12/09/2010 | CA2764327A1 Ophthalmic oil-in-water emulsions containing cyclosporine or a polyphenol |
12/09/2010 | CA2764326A1 Therapeutic ophthalmic emulsions |
12/09/2010 | CA2764227A1 Formulations for the treatment of deep tissue pain |
12/09/2010 | CA2764204A1 Spray-dried dye compositions, process for the production and use thereof |
12/09/2010 | CA2764134A1 Compositions and methods for preventing sternal wound infections |
12/09/2010 | CA2764051A1 Stabilised composition comprising at least one adrenergic compound |
12/09/2010 | CA2764050A1 Stabilised composition comprising at least one adrenergic compound |
12/09/2010 | CA2763989A1 Immuno-compatible hydrogel system |
12/09/2010 | CA2763458A1 Topical micro-emulsions for the treatment of rheumatic disorders |
12/09/2010 | CA2763040A1 Methods and compositions for the treatment of cancer |
12/09/2010 | CA2762918A1 Preparation method of drug loaded emulsion |
12/09/2010 | CA2758812A1 Method to stabilize a dietary supplement comprising glucosamine |
12/08/2010 | EP2258742A1 Polyhydroxyalkanoate compositons having controlled degradation rates |
12/08/2010 | EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides |
12/08/2010 | EP2258447A2 Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy |
12/08/2010 | EP2258441A2 Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs |
12/08/2010 | EP2258440A2 Implantable devices for delivering drugs and other substances to treat sinusitis and other disorders |
12/08/2010 | EP2258407A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
12/08/2010 | EP2258402A2 Dried composition |
12/08/2010 | EP2258396A1 Transdermally absorbable preparation |
12/08/2010 | EP2258395A1 Therapeutic agent for fibroid lung |
12/08/2010 | EP2258394A1 Oral dosage form comprising a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
12/08/2010 | EP2258390A1 Improved bacterial outer membrane vesicles |